Teladoc Health Inc(TDOC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.99 | Insider Own | 0.72% | Shs Outstand | 181.7M | Perf Week | 8.9% |
| Market Cap | 1.13B | Forward P/E | - | EPS next Y | 29.84% | Insider Trans | -10.66% | Shs Float | 180.4M | Perf Month | 2.46% |
| Enterprise Value | 1.40B | PEG | - | EPS next Q | -0.22 | Inst Own | 86.52% | Short Float | 16.69% | Perf Quarter | -33.33% |
| Income | -0.18B | P/S | 0.46 | EPS this Y | 23.71% | Inst Trans | 7.31% | Short Ratio | 7.17 | Perf Half Y | 6.67% |
| Sales | 2.49B | P/B | 0.87 | EPS next 5Y | 21.33% | ROA | -6.28% | Short Interest | 30.10M | Perf YTD | -10.86% |
| Book/sh | 7.21 | P/C | 1.46 | EPS past 3/5Y | 76.23% 26.67% | ROE | -12.99% | 52W High | -36.89% ($9.89) | Perf Year | -34.04% |
| Cash/sh | 4.26 | P/FCF | 4.54 | Sales past 3/5Y | 1.68% 18.26% | ROIC | -13.24% | 52W Low | 41.82% ($4.40) | Perf 3Y | -61.22% |
| Dividend Est. | - | EV/EBITDA | 6.01 | EPS Y/Y TTM | 16.88% | Gross Margin | 54.25% | Volatility(W/M) | 4.14% 4.27% | Perf 5Y | -95.58% |
| Dividend TTM | - | EV/Sales | 0.56 | Sales Y/Y TTM | -2.08% | Oper. Margin | -5.85% | ATR (14) | 0.25 | Perf 10Y | -58.95% |
| Dividend Ex-Date | - | Quick Ratio | 0.78 | EPS Q/Q | -15.72% | Profit Margin | -7.13% | RSI (14) | 54.67 | Recom | 2.57 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.81 | Sales Q/Q | -3.95% | SMA20 | 6.05% ($5.88) | Beta | 2.08 | Target Price | $7.39 |
| Payout | - | Debt/Eq | 0.79 | Earnings | 2026/10/28 | SMA50 | 1.57% ($6.14) | Rel Volume | 0.81 | Prev Close | $6.34 |
| Employees | 5600 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | 15.9% -1.38% | SMA200 | -3.38% ($6.46) | Avg Volume(3M) | 4.20M | Price | $6.24 |
| IPO | 2015/7/1 | Option/Short | Yes/Yes | Trades | 13554 | Volume | 3,395,505 | Change | -1.58% |
🩺 Teladoc Health (TDOC) is a global leader in the telehealth (telemedicine) field. It provides virtual healthcare services ranging from general medical care and chronic disease management to specialist consultations and mental health, serving corporate/insurance clients as well as individual consumers. The company operates along two main pillars: its integrated care platform and its mental health platform BetterHelp, and is widely regarded as a representative stock benefiting from the digital healthcare transformation.
Over the past 1 year, roughly in the middle
37% below its 1-year high.
Traded about as much as usual. That is 81% of its average volume.
Next earnings report: October 28
1 days to go.
TDOC has weak earning power
Of every $100 in sales, $5.85 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +23.7% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $46. Peers typically go for $166.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -95.6%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 86.5%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #15 of 41 in the industry
Based on market cap of $1B.
FAQ
What kind of company is TDOC?
TDOC belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of TDOC?
The market cap of TDOC is approximately $1.1B, ranking 2,464 within its sector.
What is the 52-week high and low for TDOC?
TDOC has recorded a 52-week high of $9.89 and a low of $4.40.